taxonomy (1)
protein (1)
source (4)
structure (48)
composition (50)
disease (2)
reference (7)
site (13)
peptide (11)
- Homo sapiens (Human)
Taxonomy
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)[GalNAc(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Fuc(a1-2)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)][GlcNAc(b1-4)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-2)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x Gal(b1-4)GlcNAc(b1-3)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 2 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 3 x Man(a1-2)"
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ 4 x Man(a1-2)"
- O-Linked / Core 1 / Gal(b1-3)GalNAc
- O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
Reported structure
- Hex:1 HexNAc:1 (avg mass : 383.3527 )
- Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 2386.1655 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 (avg mass : 2736.5316 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:9 HexNAc:7 dHex:1 (avg mass : 3045.8049 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. (1992 - Matsui T, Titani K, Mizuochi T) / Status : Reviewed
- Carbohydrate analysis of human von Willebrand factor with horseradish peroxidase-conjugated lectins. (1991 - Matsui T, Kihara C, Fujimura Y, Mizuochi T, Titani K) / Status : Reviewed
- Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor. (1989 - Samor B, Michalski J, Mazurier C, Goudemand M, De Waard P, Vliegenthart J, Strecker G, Montreuil J) / Status : Reviewed
Reference
- Von willebrand factor / Homo sapiens
Reported glycosite
- ASPPSSSCNISSGEMQK (17aa)
- DCNTCICR (8aa)
- GQVYLQCGTPCNLTCR (16aa)
- WNCTDHVCDATCSTIGMAHYLTFDGLK (27aa)
- IGEADFNR (8aa)
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
- VNCTTQPCPTAK (12aa)
- NVSCPQLEVPVCPSGFQLSCK (21aa)
- MEACMINGTVIGPGK (15aa)
- MEACMLNGTVIGPGK (15aa)
- TEPMQVALHCTNGSVVYHEVLNAMECK (27aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1276.1699)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1422.3129)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1479.3649)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1625.5079)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1641.5073)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1682.5599)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1787.6503)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 1828.7029)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1844.7023)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1933.7933)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1933.7933)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1990.8453)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1990.8453)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1990.8453)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1990.8453)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1990.8453)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2006.8447)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2006.8447)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2095.9357)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 2095.9357)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 2136.9883)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2136.9883)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2136.9883)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2136.9883)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2136.9883)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2152.9877)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2152.9877)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2152.9877)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2283.1313)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2299.1307)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2372.1821)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2372.1821)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2518.3251)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2518.3251)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2737.5195)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 2737.5195)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / Complex (avg mass : 2883.6625)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2883.6625)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1397.2597)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
-
- N-Linked / High-Mannose (avg mass : 1559.4021)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1721.5445)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / High-Mannose (avg mass : 1883.6869)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- O-Linked / Core 1 (avg mass : 383.3527)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- O-Linked / Core 1 (avg mass : 965.8685)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- Hex:9 HexNAc:7 dHex:1 / N-Linked (avg mass : 3045.8049)
- Von willebrand factor / Homo sapiens
-
- Hex:1 HexNAc:2 / N-Linked (avg mass : 586.5477)
- Von willebrand factor / Homo sapiens
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Von willebrand factor / Homo sapiens
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Von willebrand factor / Homo sapiens
- MEACMLNGTVIGPGK (15aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- Von willebrand factor / Homo sapiens
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Von willebrand factor / Homo sapiens
- WNCTDHVCDATCSTIGMAHYLTFDGLK (27aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- GQVYLQCGTPCNLTCR (16aa)
- WNCTDHVCDATCSTIGMAHYLTFDGLK (27aa)
- IGEADFNR (8aa)
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
- NVSCPQLEVPVCPSGFQLSCK (21aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Blood Serum (UBERON_0001977)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Prostate cancer (DOID:10283)
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- GQVYLQCGTPCNLTCR (16aa)
- MEACMLNGTVIGPGK (15aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Cancer, breast (DOID:1612)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- GQVYLQCGTPCNLTCR (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Prostate cancer (DOID:10283)
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- MEACMLNGTVIGPGK (15aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Von willebrand factor / Homo sapiens
- DCNTCICR (8aa)
- GQVYLQCGTPCNLTCR (16aa)
- MEACMINGTVIGPGK (15aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Von willebrand factor / Homo sapiens
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Von willebrand factor / Homo sapiens
- GQVYLQCGTPCNLTCR (16aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Von willebrand factor / Homo sapiens
- ASPPSSSCNISSGEMQK (17aa)
- GQVYLQCGTPCNLTCR (16aa)
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
- NVSCPQLEVPVCPSGFQLSCK (21aa)
- MEACMINGTVIGPGK (15aa)
- TEPMQVALHCTNGSVVYHEVLNAMECK (27aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Von willebrand factor / Homo sapiens
-
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked (avg mass : 2371.1942)
- Von willebrand factor / Homo sapiens
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 / N-Linked (avg mass : 2386.1655)
- Von willebrand factor / Homo sapiens
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Blood Serum (UBERON_0001977)
- Von willebrand factor / Homo sapiens
- HCDGNVSSCGDHPSEGCFCPPDK (23aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Von willebrand factor / Homo sapiens
- VNCTTQPCPTAK (12aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Von willebrand factor / Homo sapiens
- MEACMLNGTVIGPGK (15aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Prostate cancer (DOID:10283)
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- MEACMLNGTVIGPGK (15aa)
-
- Hex:6 HexNAc:5 dHex:3 NeuAc:1 / N-Linked (avg mass : 2736.5316)
- Von willebrand factor / Homo sapiens
-
- Hex:8 HexNAc:7 / N-Linked (avg mass : 2737.5195)
- Von willebrand factor / Homo sapiens
-
- Hex:6 HexNAc:5 NeuAc:3 / N-Linked (avg mass : 2880.6184)
- Von willebrand factor / Homo sapiens
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 / N-Linked (avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Prostate cancer (DOID:10283)
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Von willebrand factor / Homo sapiens
- MEACMLNGTVIGPGK (15aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Von willebrand factor / Homo sapiens
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
